Healthy participants Trials in Baltimore, United States
Conditions / Healthy participants / Baltimore, United States
Healthy participants has been the subject of sustained clinical investigation across multiple research sites.
19 total trials for this combination
Showing top 10 of 19 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04452318 | COVID-19 Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household Contacts to an Individual With a Positive SARS-CoV-2 RT-PCR Assay | COMPLETED | PHASE3 |
| NCT07224074 | Impact of Exogenous Ketones on Sleep and Breathing in Healthy Volunteers (K-SLEEP) | RECRUITING | PHASE1 |
| NCT06942936 | A Study to Investigate the Impact of Multiple Doses of Itraconazole on AZD5004 in Healthy Participants and Multiple Doses of AZD5004 on Combined Oral Ethinyl Oestradiol and Levonorgestrel in Healthy Female Participants | COMPLETED | PHASE1 |
| NCT06469151 | A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AZD5148 in Healthy Adults | COMPLETED | PHASE1 |
| NCT07300085 | A Trial to Evaluate the Effect of CD388 on the Immunogenicity of Fluzone® HD Vaccine | RECRUITING | PHASE1 |
| NCT07290283 | A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD3974 in Healthy Participants | RECRUITING | — |
| NCT04971395 | Safety, Tolerability, and Pharmacokinetics of a Single Intravenous Infusion of XTMAB-16 in Healthy Adult Participants | COMPLETED | PHASE1 |
| NCT03036865 | Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of BOS161721 in Healthy Subjects | COMPLETED | PHASE1 |
| NCT06072157 | Study to Assess the Safety, Tolerability, Pharmacokinetics and Immunogenicity of AK006 in Healthy Subjects and Subjects With Chronic Spontaneous Urticaria | COMPLETED | PHASE1 |
| NCT06908577 | An Accessorised Prefilled Syringe to an Autoinjector Pharmacokinetic Bridging Study of Tozorakimab | COMPLETED | PHASE1 |